Financials

News Discussions Technicals Seasonals

2257 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Sirnaomics Ltd. operates as a holding company, which engages in research and development of clinical drugs. It is also involved in the development and manufacturing of RNA interference therapeutics. Its product pipeline includes STP705, STP707, RV-1730, and GalAhead. The company was founded by Yang Lu on October 15, 2020 and is headquartered in Hong Kong.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

2257 does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company